U.S. Total Fertility Rate Conditional Policy Event Contract

0. Document Status and Non-Legal Disclaimer

This anonymized example is a non-legal product-design and settlement-methodology specification. It is intended to show the structure and level of detail of an individualized consulting deliverable for internal DCM product, compliance, operations, market surveillance, and legal review.

This document is not legal advice, not a legal opinion, not regulatory representation, not a CFTC compliance determination, not a CFTC self-certification, not a request for CFTC approval, and not a representation that any contract, market, product, rule, or submission is lawful, CFTC-compliant, acceptable to the CFTC, approvable by the CFTC, or not contrary to the public interest.

All legal, regulatory, filing-path, certification, approval-request, and submission decisions must be made by the DCM and its qualified legal counsel and authorized compliance personnel.

1. Executive Summary

1.1 Proposed Market

Market name: U.S. Total Fertility Rate Above Threshold if Policy Enacted

Plain-English market question: Will the final U.S. national total fertility rate for calendar year 2030 be higher than {total_fertility_rate} if {policy} is enacted and effective by {policy_effective_deadline}?

Event category: Demographic indicator / policy-conditional decision event

Proposed contract type: Conditional binary Yes/No event contract

Recurring or one-off: Case-by-case policy-conditional market, with any later issuance requiring separate review of the policy trigger, source hierarchy, and settlement timing

1.2 Intended Information Signal

The proposed contract is intended to aggregate market expectations about whether a specified government policy, if enacted by a defined deadline, is associated with a final national U.S. total fertility rate above a stated threshold for calendar year 2030.

Potential users of the information signal may include public-policy analysts, demographic researchers, institutions monitoring long-term population assumptions, and market participants seeking a public information signal.

1.3 Specification Summary

Underlying event: Final U.S. national total fertility rate for calendar year 2030, conditional on enactment and effectiveness of {policy} by {policy_effective_deadline}.

Primary source: CDC/NCHS/NVSS final birth publication for 2030.

Supporting primary evidence: CDC WONDER Natality final data, used for auditability, age-specific rates, and consistency checks.

Expiration trigger: The fertility observation period ends on 31 December 2030, but settlement waits for final CDC/NCHS publication of the 2030 total fertility rate.

Policy trigger: {policy} must be enacted and effective by {policy_effective_deadline}, as verified through the designated official policy source.

Proposed Yes condition: The policy trigger is satisfied and the final 2030 U.S. total fertility rate is strictly higher than {total_fertility_rate}.

Proposed No condition: The policy trigger is satisfied and the final 2030 U.S. total fertility rate is less than or equal to {total_fertility_rate}.

No-determination condition: If the policy trigger is not satisfied, the contract should enter DCM review / no-determination handling under the DCM’s applicable rules, rather than resolving from fertility data alone.

1.4 Key Design Questions for DCM Review

1. Which official legal source should determine whether {policy} has been enacted and become effective?
2. Should a policy count if enacted before the deadline but funded, suspended, repealed, or materially narrowed before 2030?
3. Should settlement use the final NCHS total fertility rate as published, or a CDC WONDER-derived calculation if publication formats differ?
4. Which participant categories require restricted-person review because of policy influence, data-release access, or non-public demographic data access?

2. Market Idea and Product Rationale

2.1 Market Thesis

The market is designed to price the probability that, conditional on a defined policy being enacted and effective by a defined deadline, the final U.S. national total fertility rate for calendar year 2030 will exceed a specified threshold.

The intended signal concerns a measurable national demographic indicator under a defined policy condition. It does not evaluate whether the policy is advisable, lawful, cost-effective, politically desirable, or causally responsible for the resulting fertility rate.

2.2 User Need / Market Use Case

Market participants may find the price signal useful for information aggregation, demographic forecasting, public-policy scenario analysis, and institutional decision support.

The conditional structure may be especially useful where the relevant question is not only “What will the 2030 fertility rate be?” but “What fertility-rate outcome should be expected if a particular policy is enacted?“

2.3 Why an Event Contract Structure May Be Useful

A binary event-contract structure may be useful because the relevant uncertainty can be expressed as a discrete threshold question, while the policy condition separates the policy trigger from the later demographic data outcome.

The contract should be drafted to avoid implying causal proof. The settlement question is whether the policy trigger occurred and whether the official final fertility-rate value exceeded the threshold.

3. Contract Family Definition

3.1 Contract Family Name

U.S. Total Fertility Rate Conditional Policy Market

3.2 Contract Family Formula

Will the final U.S. national total fertility rate for calendar year 2030 be higher than {total_fertility_rate} if {policy} is enacted and effective by {policy_effective_deadline}?

3.3 Variable Placeholders

Placeholder	Meaning	Allowed Values	Excluded Values	Notes
{total_fertility_rate}	Numeric threshold for the final U.S. national total fertility rate	Positive numeric value expressed as births per woman	Ambiguous thresholds, ranges, or values without precision rules	Example thresholds should remain illustrative unless final DCM terms specify a value.
{policy}	Government policy whose enactment creates the conditional branch	Precisely identified federal policy with legal source, effective date, funding status, and duration	Broad policy themes, campaign proposals, unenacted statements, or state-only policies without separate review	Federal policy is preferred because the outcome metric is national.
{policy_effective_deadline}	Deadline by which the policy must be enacted and effective	Calendar date and time with timezone	Open-ended phrases such as “before 2030” without exact time	This is separate from the fertility observation period and settlement publication date.
{source}	Source for final fertility data	CDC/NCHS/NVSS final birth publication, with CDC WONDER support	Unofficial commentary, media summaries, or convenience data views as controlling sources	UN and World Bank are secondary/fallback sources only.
{settlement_publication_deadline}	Latest publication date to wait for final source data before review	Calendar date after expected final NCHS publication	Settlement before final data publication	Final date should reflect NCHS release practice and DCM operational needs.

3.4 Permitted Market Instances

1. A market tied to a precisely identified federal U.S. policy with an official enactment source.
2. A market using the final U.S. national total fertility rate for calendar year 2030 as the demographic outcome.
3. A market where {total_fertility_rate} is stated with clear precision, comparison, and display rules.

3.5 Excluded Market Instances

1. Policies described only by political slogan, policy theme, or campaign promise.
2. State, local, or private policies unless separately reviewed for whether they can reasonably be paired with a national metric.
3. Markets requiring an unofficial forecast, provisional estimate, or model-derived fertility value to control settlement.
4. Markets that ask whether a policy caused the fertility rate to change.

3.6 Scalability Notes

Comparable markets may be possible only after separate review of each policy trigger, legal source, implementation timing, funding condition, repeal treatment, demographic source hierarchy, and restricted-participant concerns.

4. Contract Question

4.1 User-Facing Question

Will the final U.S. national total fertility rate for 2030 be higher than {total_fertility_rate} if {policy} is enacted and effective by {policy_effective_deadline}?

4.2 Precise Market Question

If {policy} is enacted and effective by {policy_effective_deadline}, will CDC/NCHS publish a final U.S. national total fertility rate for calendar year 2030 that is strictly higher than {total_fertility_rate}, expressed as births per woman?

4.3 Rulebook-Style Question

The Contract resolves to Yes if the Policy Trigger is satisfied and the Final 2030 TFR is greater than the Threshold, subject to the resolution methodology described in this specification.

If the Policy Trigger is not satisfied, the Contract enters the DCM’s no-determination or review process, rather than resolving by reference to the Final 2030 TFR alone.

4.4 Ambiguity Check

Potential Ambiguity	Proposed Clarification	Open Question for DCM/Counsel
”If policy” could imply causation	Settlement does not determine causation; it only observes the policy trigger and final TFR threshold condition.	Are additional customer-facing disclosures needed?
Policy enacted but not funded	Does not satisfy the Policy Trigger unless final terms expressly include unfunded enactment.	Should funding be a required element for every policy type?
Policy partially effective by deadline	Review unless final terms specify a partial-effectiveness rule.	Which policy components are essential?
Final NCHS report and CDC WONDER data differ	Final NCHS report controls unless review rules select another source.	Should CDC WONDER be a verification source or a fallback source?

5. Underlying Event

5.1 Underlying

The Underlying is the final U.S. national total fertility rate for calendar year 2030, conditional on satisfaction of the specified Policy Trigger.

5.2 Included Events / Data / Decisions

• Final NCHS/NVSS birth publication reporting the U.S. total fertility rate for calendar year 2030.
• CDC WONDER Natality final data used to verify age-specific fertility rates, live birth counts, or consistency with the final publication.
• Official legal enactment and effectiveness records for {policy}.
• Official corrections published before final settlement observation, if final rules permit correction treatment.

5.3 Excluded Events / Data / Decisions

• Provisional fertility estimates unless expressly included for review only.
• Unofficial projections, models, commentary, or media summaries.
• Internationally harmonized estimates as controlling settlement values unless the primary source is unavailable and review rules authorize fallback use.
• State-only policy changes unless separately reviewed and expressly included.
• Any determination that {policy} caused, failed to cause, or materially affected the fertility rate.

5.4 Observation Unit

Observation unit: U.S. national total fertility rate for calendar year 2030, expressed as births per woman.

5.5 Observation Period

Fertility observation period: 1 January 2030 through 31 December 2030.

Policy trigger period: From contract listing through {policy_effective_deadline}.

5.6 Event Boundary

The fertility event ends at the end of calendar year 2030. Settlement occurs only after the final CDC/NCHS publication of the 2030 fertility value, unless the DCM initiates review under its applicable rules.

The policy event is separate. The Policy Trigger must be satisfied by {policy_effective_deadline} before the fertility value can determine a Yes or No outcome.

6. Defined Terms

Term	Proposed Definition	Notes / Open Questions
Final 2030 TFR	The final U.S. national total fertility rate for calendar year 2030 published by CDC/NCHS/NVSS.	Expressed for settlement as births per woman.
Threshold	{total_fertility_rate}, stated as births per woman.	Final terms must state precision.
Policy	The exact government policy identified in final contract terms.	Must include legal source and required components.
Policy Trigger	Enactment and effectiveness of {policy} by {policy_effective_deadline}.	Funding, repeal, and suspension treatment must be specified.
Policy Source	The official legal or governmental source used to verify Policy Trigger satisfaction.	Example: statute, Federal Register notice, agency rule, or official budget authority record.
Fertility Observation Period	Calendar year 2030.	Separate from settlement date.
Settlement Publication Date	The date on which CDC/NCHS publishes the final source value used for settlement.	Expected after 31 December 2030.
Final Publication	The final, non-provisional NCHS source publication reporting the relevant 2030 value.	Provisional releases do not control.
Market Outcome Review	DCM process for reviewing source unavailability, source conflict, policy ambiguity, or no-determination conditions.	Must align with DCM rules.

7. Source Architecture

7.1 Source Design Goal

The source architecture is intended to support objective, auditable, and operationally reliable settlement for both parts of the contract: the Policy Trigger and the final demographic value.

7.2 Primary Source

Primary Source: CDC/NCHS/NVSS final birth publication for 2030.

Publication channel / URL: CDC/NCHS Birth Data

CDC/NCHS describes the National Vital Statistics System birth data as the federal compilation of birth-certificate data produced through cooperation between NCHS and the states.

Characteristic	Yes / No / Unknown	Notes
Publicly available	Yes	Published by CDC/NCHS.
Official source	Yes	U.S. federal health statistics source.
Timestamped	Yes	Publication date is normally available.
Archived	Unknown	Archive workflow should be confirmed by DCM operations.
Independent from the Exchange	Yes	Source is external to the DCM.
Human-verifiable	Yes	Final publication can be reviewed by operations staff.
Machine-readable	Unknown	Supporting data may be available through CDC WONDER or data files.

7.3 Secondary Source

Secondary Source: United Nations World Population Prospects.

Publication channel / URL: UN World Population Prospects

Use condition: Use for internationally harmonized comparison and fallback review context only, unless final DCM rules expressly authorize secondary-source settlement.

7.4 Fallback Source

Fallback Source: World Bank SP.DYN.TFRT.IN.

Publication channel / URL: World Bank metadata for SP.DYN.TFRT.IN

Use condition: Use only after DCM review if primary and secondary sources are unavailable, materially unusable, or no longer reliable for the relevant metric.

7.5 Source Hierarchy

1. Primary Source: CDC/NCHS/NVSS final birth publication for 2030.
2. Supporting primary evidence: CDC WONDER Natality documentation and final CDC WONDER Natality data.
3. Secondary Source: UN World Population Prospects.
4. Fallback Source: World Bank SP.DYN.TFRT.IN, after review.
5. Convenience-only sources: FRED and Our World in Data for visualization or exploration, not settlement.

7.6 Conflicting-Source Rule

If sources conflict, the highest-ranked available source in the source hierarchy controls, unless the DCM initiates a market outcome review under its applicable rules.

7.7 Source Revision Rule

Corrections or revisions to the primary source before settlement observation may be considered if final DCM rules permit. Revisions published after settlement should not change settlement unless the DCM’s final rules provide otherwise.

7.8 Source Unavailability Rule

If the primary source is unavailable at the expected settlement observation time, operations should document the outage, capture available evidence, and escalate under the DCM’s market outcome review process.

7.9 Source Reliability Concerns

Concern	Description	Possible Design Mitigation	Open Question
Final data publication delayed	NCHS final 2030 publication may occur well after 31 December 2030.	Settlement date should be publication-based, not year-end-based.	What latest publication date should trigger review?
Provisional and final values differ	Provisional birth releases may precede final data.	Final publication controls.	Should provisional data ever be used for informational display?
Unit mismatch	NCHS may display TFR per 1,000 women while market threshold is births per woman.	Convert only for display and comparison using a stated convention.	Confirm precision and display standard.
Source revision	Final report or data table may be corrected.	Timing-based correction rule.	Are post-settlement corrections ignored?
Policy source ambiguity	Legal enactment and effectiveness may require interpretation.	Define Policy Source and essential policy components.	Counsel must review trigger wording.

8. Settlement Methodology

8.1 Settlement Input

The settlement inputs are:

1. Whether the Policy Trigger was satisfied by {policy_effective_deadline}.
2. The Final 2030 TFR from the primary source, if the Policy Trigger was satisfied.

8.2 Settlement Observation Time

Policy observation time: As soon as practicable after {policy_effective_deadline}.

Fertility observation time: As soon as practicable after CDC/NCHS publishes the final source value for calendar year 2030.

8.3 Expiration Date and Expiration Time

Fertility observation period end: 31 December 2030 at 11:59:59 p.m. Eastern Time, unless final DCM rules specify another timezone.

Policy effective deadline: {policy_effective_deadline}, stated in final contract terms.

Settlement publication deadline: To be inserted after review of NCHS release practices and DCM operational requirements.

8.4 Settlement Date

Settlement Date: The next DCM business day after the final source value is available and the Policy Trigger status has been determined, unless review is triggered.

8.5 Settlement Value

Settlement Value: Yes if the Policy Trigger is true and the Final 2030 TFR is greater than the Threshold; No if the Policy Trigger is true and the Final 2030 TFR is less than or equal to the Threshold; Review / no-determination if the Policy Trigger is not satisfied or a review trigger applies.

8.6 Rounding and Precision

Precision: The Threshold is expressed as births per woman. If NCHS publishes TFR as births per 1,000 women, divide the published value by 1,000 for display and comparison.

Rounding convention: Do not perform intermediate rounding. Compare the converted value to {total_fertility_rate} at the precision stated in final contract terms.

8.7 Treatment of Missing Data

If final 2030 TFR data are missing after the expected publication window, the contract should enter review rather than using provisional or unofficial data by default.

8.8 Treatment of Corrected Data

Corrections published before settlement observation may be considered under final DCM rules. Corrections published after settlement should not change settlement unless the DCM’s final rules provide otherwise.

8.9 Treatment of Withdrawn Publications

If a final publication is withdrawn before settlement, the contract should enter review. If a publication is withdrawn after settlement, treatment should follow the DCM’s final correction and dispute rules.

8.10 Manual Review Trigger

A manual review may be triggered if:

• The Policy Trigger is ambiguous or disputed.
• The policy is enacted but not funded, suspended, repealed, or materially narrowed before 2030.
• The primary source is unavailable or materially changed.
• Final NCHS and CDC WONDER evidence conflict in a way that affects the threshold comparison.
• NCHS changes the published definition or unit of the total fertility rate.

8.11 Settlement Examples

Scenario	Policy Trigger	Final 2030 TFR	Proposed Outcome	Notes
Example 1	Satisfied	Above threshold	Yes	Policy and fertility conditions both satisfied.
Example 2	Satisfied	Equal to threshold	No	”Higher than” requires strict greater-than comparison.
Example 3	Satisfied	Below threshold	No	Policy trigger true, threshold condition false.
Example 4	Not satisfied	Any value	Review / no-determination	Fertility data alone do not settle the contract.
Example 5	Ambiguous	Above threshold	Review	Policy-source interpretation required.

9. Yes / No / Review Logic

9.1 Yes Logic

The proposed contract resolves to Yes if all of the following conditions are satisfied:

1. {policy} is enacted and effective by {policy_effective_deadline}.
2. The final CDC/NCHS source value for the 2030 U.S. national total fertility rate is available.
3. The Final 2030 TFR is strictly greater than {total_fertility_rate}.

9.2 No Logic

The proposed contract resolves to No if all of the following conditions are satisfied:

1. {policy} is enacted and effective by {policy_effective_deadline}.
2. The final CDC/NCHS source value for the 2030 U.S. national total fertility rate is available.
3. The Final 2030 TFR is less than or equal to {total_fertility_rate}.

9.3 Review / No-Determination Logic

The proposed contract may require DCM review or no-determination handling if:

1. The Policy Trigger is not satisfied.
2. The Policy Trigger status is ambiguous.
3. The final source value is missing, withdrawn, or materially disputed.
4. The source hierarchy produces conflicting values that affect the threshold comparison.

9.4 Boolean Logic Representation

YES = POLICY_TRIGGER_TRUE AND FINAL_2030_TFR > THRESHOLD
NO = POLICY_TRIGGER_TRUE AND FINAL_2030_TFR <= THRESHOLD
REVIEW = NOT POLICY_TRIGGER_TRUE OR POLICY_TRIGGER_AMBIGUOUS OR SOURCE_UNAVAILABLE OR SOURCE_CONFLICT

10. Edge Cases

#	Scenario	Proposed Treatment	Product Rationale	Open Question for DCM/Counsel
1	Policy is enacted after the deadline	Review / no-determination	The conditional trigger failed by deadline.	Should failed trigger always be no-determination?
2	Policy enacted but effective date is after the deadline	Review / no-determination	Enactment alone is insufficient under this draft.	Should enactment and effectiveness be separate triggers?
3	Policy enacted but funding expires before 2030	Review	Outcome may not reflect the stated policy condition.	Should a minimum duration be required?
4	Policy is repealed before 2030	Review	Conditional branch may no longer describe the observed world.	Should repeal before a cutoff negate the trigger?
5	Final TFR equals threshold	No	”Higher than” is a strict comparison.	Confirm customer-facing wording.
6	NCHS publishes per-1,000 value only	Convert by dividing by 1,000	Maintains births-per-woman threshold convention.	Confirm decimal precision.
7	NCHS final report is delayed	Wait until final publication or review deadline	Final data should control.	Define latest permissible settlement delay.
8	CDC WONDER and NCHS final report differ	NCHS final report controls, subject to review	Supports a clear hierarchy.	Should CDC WONDER ever override a report typo?
9	UN or World Bank value differs from NCHS	NCHS controls	Harmonized estimates are not the primary U.S. source.	Confirm fallback conditions.
10	State policy variant proposed	Separate review	National TFR may be a poor source match for state-only policy.	Should state markets use state-level rates instead?

11. Manipulation Surface

11.1 Purpose

This section identifies potential manipulation surfaces and product-design mitigations for DCM review.

11.2 Outcome Influence Map

Actor / Group	Can Influence Outcome?	Can Influence Source?	Has Pre-Publication Access?	Notes
Federal lawmakers and executive officials	Yes	No	Unknown	May influence enactment, funding, repeal, or implementation.
Agency officials implementing policy	Yes	Unknown	Unknown	May affect effective-date and implementation evidence.
NCHS / vital statistics personnel	No	Yes	Yes	Source-publication and data-access concerns require review.
State vital statistics offices	No	Yes	Unknown	Birth-certificate data flow may affect final data.
General public	No	No	No	Ordinary informational participants.

11.3 Potential Manipulation Vectors

Vector	Description	Possible Product-Design Mitigation	Residual Concern
Policy-trigger influence	Officials may influence enactment, funding, or effective-date status.	Restricted participant review and policy-source clarity.	Legal/compliance review required.
Data-release access	Data personnel may know final values before publication.	Restricted categories and surveillance near publication.	Pre-publication access may remain.
Source interpretation	Ambiguous policy components may affect trigger status.	Define essential policy components before listing.	Counsel review required.
Timing manipulation	Policy effective date or publication timing may be adjusted.	Fixed deadlines and review triggers.	Single-actor influence may remain.

11.4 Possible Operational Mitigations for DCM Review

• Restricted participant categories.
• Policy-trigger evidence archive.
• Source-publication archive.
• Settlement-window surveillance.
• Official source hierarchy.
• Manual escalation workflow.
• Customer-facing language distinguishing settlement from causal inference.

11.5 Residual Design Concerns

The main residual concerns are policy-trigger influence by government actors, pre-publication access to demographic data, source timing uncertainty, and the risk that users may overread the market as a causal claim.

12. Restricted Participants

12.1 Purpose

This section identifies categories of persons or institutions that may present event-specific information, influence, or conflict concerns. It does not determine the final restricted-person policy.

12.2 Potential Restricted Categories for Review

Category	Reason for Review	Possible Scope	Open Question
Federal officials involved in {policy}	Direct influence over Policy Trigger	Officials with drafting, voting, approval, funding, or implementation authority	Which offices and committees should be included?
Agency personnel implementing policy	Effective-date and implementation influence	Personnel with direct implementation duties	Should contractors be included?
NCHS or vital statistics personnel	Source access and pre-publication data	Personnel with access to unpublished final data or publication control	How broad should the restriction be?
Policy advisors and contractors	Non-public policy information	Advisors with material non-public information	Should external consultants be covered?
Immediate family / household members	Indirect information or influence concerns	As defined by DCM policy	Is this appropriate for this event?

12.3 Potential Attestation Questions

1. Do you have authority to influence enactment, funding, effectiveness, repeal, or implementation of {policy}?
2. Do you have non-public information about whether {policy} will satisfy the Policy Trigger?
3. Do you have non-public access to final or pre-publication 2030 U.S. fertility-rate data?

12.4 Monitoring Considerations

Monitoring may focus on trading around policy deadlines, official enactment events, funding decisions, implementation announcements, expected NCHS publication windows, and any unusual activity by accounts connected to restricted categories if the DCM adopts such restrictions.

13. Operational Requirements

Operational Area	Possible Requirement	Notes
Policy-source monitoring	Monitor official legal source for enactment and effectiveness.	Must identify legal source before listing.
Fertility-source monitoring	Monitor NCHS final birth publications and CDC WONDER data availability.	Settlement occurs after final publication.
Publication archive	Capture policy and fertility source evidence.	Supports auditability.
Review workflow	Escalate policy ambiguity, source unavailability, or source conflict.	Must align with DCM rules.
Restricted list implementation	Apply any event-specific restrictions approved by DCM.	Counsel/compliance decision required.
Customer-facing market description	Match conditional rulebook-style terms.	Avoid causal or policy-advocacy wording.

14. Counsel and Compliance Questions

14.1 Filing Path

1. Should this market be considered for 40.2 self-certification, 40.3 request for approval, pre-filing engagement, or no filing?
2. Is the conditional policy structure sufficiently novel, sensitive, or complex to justify prior CFTC engagement?
3. Are there reasons not to pursue a demographic policy-conditional event contract?

14.2 Public Interest / 40.11 Review

1. Could the contract create incentives to influence, delay, fund, repeal, or modify public policy for trading-related reasons?
2. Could the contract be characterized as involving gaming, public-policy interference, or other sensitive activity?
3. Are there privacy-law, health-data, administrative-law, or election-law issues requiring review?

14.3 Manipulation and Market Integrity

1. Are the proposed settlement sources sufficiently objective and reliable?
2. Are additional controls needed for government actors, policy advisors, or data personnel?
3. Are position limits, position accountability, or special surveillance measures needed?

14.4 Restricted Participants and MNPI

1. Which participant categories should be restricted, if any?
2. Are household or immediate-family restrictions appropriate?
3. Are attestations, monitoring, or information-sharing arrangements needed?

14.5 Customer-Facing Description

1. Is the customer-facing question clear that the contract is conditional on policy enactment?
2. Does the wording avoid implying causal proof?
3. Are additional disclosures needed for no-determination treatment if the Policy Trigger fails?

15. Filing-Preparation Support

This section organizes filing-adjacent materials for review by the DCM, compliance personnel, market surveillance, operations, and qualified counsel.

15.1 Filing Readiness Checklist

Area	Status in This Specification	Remaining Owner
Product concept and market question	Drafted for review.	DCM product team and counsel
Policy-trigger terms	Drafted at example level.	Product, operations, and counsel
Fertility metric and source hierarchy	Drafted with CDC/NCHS primary source.	Product and operations
Edge-case and review-trigger analysis	Proposed, with open questions.	Product, operations, and counsel
Restricted-participant categories	Identified for review.	Compliance and counsel
Manipulation and market-integrity surfaces	Identified at a product-design level.	Compliance, surveillance, and counsel
Legal and regulatory compliance analysis	Not provided.	Qualified counsel and authorized DCM personnel
Final filing path	Not provided.	DCM and qualified counsel

15.2 Potentially Relevant Review Areas

Review Area	Design Support Provided Here	Open Question / Required Review
Conditional settlement	Policy Trigger and fertility value are separated.	Counsel and operations must confirm no-determination treatment.
Source reliability	Primary, supporting, secondary, fallback, conflict, revision, and outage rules are proposed.	Operations and counsel must confirm final source acceptability.
Market integrity	Policy influence and pre-publication data concerns are mapped.	Surveillance must decide monitoring procedures.
Customer-facing clarity	Causal claims are excluded from settlement wording.	Product and counsel must finalize disclosures.
Participant restrictions	Candidate categories and attestations are listed.	Compliance and counsel must determine final policy.

15.3 Submission Artifact Checklist

Artifact	Prepared in This Document?	Notes
Product rules / terms and conditions	Partially drafted for review.	See rulebook-style draft below; not final rule text.
Policy-source evidence	Indexed conceptually.	Exact legal source remains to be selected.
Fertility-source evidence	Partially indexed.	Final 2030 publication unavailable until after 2030.
Compliance explanation	No.	Must be prepared by DCM and qualified counsel if needed.
Position limit or accountability proposal	Placeholder only.	Must be set by the DCM.
Surveillance procedures	Design considerations only.	Must be prepared by market surveillance.
Operational settlement procedure	Design considerations only.	Must be mapped to final exchange rules.

15.4 Assumptions and Open Decisions Register

#	Assumption / Open Decision	Why It Matters	Proposed Owner
1	{policy} is a federal U.S. policy with an official legal source.	National metric aligns better with federal policy than state-only policy.	Product / counsel
2	Policy Trigger requires enactment and effectiveness by {policy_effective_deadline}.	Avoids treating symbolic or unfunded action as equivalent to operative policy.	Product / counsel
3	Final CDC/NCHS TFR controls settlement.	Supports official U.S. source hierarchy.	Product / operations
4	CDC WONDER is supporting primary evidence, not the default controlling source.	Avoids calculation disputes unless final rules say otherwise.	Product / operations
5	UN WPP and World Bank are secondary/fallback sources only.	Preserves U.S. official-source priority.	Product / operations
6	Failed Policy Trigger leads to review / no-determination handling.	Conditional markets require explicit non-occurrence treatment.	Counsel / operations
7	Position limits or accountability levels are not specified here.	Market-size and concentration controls must align with exchange policy.	Compliance / surveillance

15.5 Evidence Pack Outline

Evidence Item	What to Collect	Review Purpose
Policy legal instrument	Statute, rule, budget authority, or official enactment record.	Confirms Policy Trigger source.
Policy effective-date evidence	Official effective date, implementation date, funding status, and duration.	Determines conditional branch.
Policy component map	Essential elements required for trigger satisfaction.	Reduces ambiguity around partial enactment.
NCHS birth-data source page	Official publication channel and expected release practice.	Supports primary source reliability.
CDC WONDER documentation	Data coverage, measures, age-specific rates, and citation details.	Supports auditability.
UN WPP source reference	Harmonized demographic comparison source.	Supports secondary review.
World Bank metadata	SP.DYN.TFRT.IN definition and source metadata.	Supports fallback review.
DCM review rules	Market outcome review, emergency authority, and no-determination rules.	Maps conditional failure treatment to actual rulebook.

16. Rulebook-Style Draft

Important: This section is draft rulebook-style text for internal DCM and counsel review.

Rule [X].[Y] - U.S. Total Fertility Rate Conditional Policy Contract

(a) General

These Contract Rules govern the trading of “U.S. Total Fertility Rate Conditional Policy Contract” on the Exchange and the clearing of the Contract through [Clearing House], if applicable.

(b) Underlying

The Underlying for each Contract is the final U.S. national total fertility rate for calendar year 2030, conditional on satisfaction of the Policy Trigger.

(c) Definitions

1. “Final 2030 TFR” means the final U.S. national total fertility rate for calendar year 2030 published by CDC/NCHS/NVSS.
2. “Threshold” means {total_fertility_rate}, expressed as births per woman.
3. “Policy” means {policy}, as identified in the Contract terms.
4. “Policy Trigger” means that the Policy is enacted and effective by {policy_effective_deadline}, as determined from the Policy Source.
5. “Policy Source” means [insert official legal source].

(d) Source Agency

The Source Agency for the Final 2030 TFR is CDC/NCHS/NVSS.

If the Source Agency is unavailable or if the Exchange determines that the Source Agency is no longer reliable for determining the Market Outcome, the Exchange may initiate a market outcome review under its applicable rules.

(e) Issuance

The Contract may be issued for the following parameters:

1. {total_fertility_rate} means the Threshold.
2. {policy} means the Policy.
3. {policy_effective_deadline} means the deadline for Policy Trigger satisfaction.
4. {settlement_publication_deadline} means the final source publication review deadline, if one is adopted.

(f) Contract Size

Each Contract has a notional value of [insert amount].

(g) Payout Criterion

The Contract resolves to Yes if the Policy Trigger is satisfied and the Final 2030 TFR is greater than the Threshold.

The Contract resolves to No if the Policy Trigger is satisfied and the Final 2030 TFR is less than or equal to the Threshold.

If the Policy Trigger is not satisfied, the Contract is subject to no-determination or review treatment under the Exchange’s applicable rules.

(h) Settlement and Expiration

The fertility observation period ends on 31 December 2030. Settlement occurs after publication of the final CDC/NCHS source value for calendar year 2030, unless review is triggered.

(i) Listing and Trading Hours

Trading shall be available [insert rule], subject to Exchange rules and maintenance windows.

(j) Position Limits or Position Accountability

[Insert proposed position limit or position accountability structure for DCM review.]

(k) Trading Prohibitions

The DCM may consider whether event-specific trading restrictions should apply to officials involved in the Policy, agency implementation personnel, NCHS or vital statistics personnel, policy advisors, contractors, household members, or other categories identified by counsel and compliance.

(l) Additional Settlement Contingencies

Before settlement, the Exchange may initiate a market outcome review if policy ambiguity, source conflict, source unavailability, publication withdrawal, unit-definition change, or data correction creates settlement ambiguity.

17. Example Iterations

#	Market Question	Policy Type	Primary Fertility Source	Notes
1	Will final 2030 U.S. TFR be higher than {total_fertility_rate} if a refundable child allowance or birth grant is enacted?	Direct family transfer	CDC/NCHS/NVSS	Requires exact benefit, eligibility, funding, and effective date.
2	Will final 2030 U.S. TFR be higher than {total_fertility_rate} if an expanded child tax credit is enacted?	Tax credit	CDC/NCHS/NVSS	Requires refundability, credit amount, duration, and eligibility definition.
3	Will final 2030 U.S. TFR be higher than {total_fertility_rate} if paid parental leave is enacted?	Leave policy	CDC/NCHS/NVSS	Requires coverage, wage replacement, job protection, and implementation date.
4	Will final 2030 U.S. TFR be higher than {total_fertility_rate} if childcare subsidy or public childcare expansion is enacted?	Childcare policy	CDC/NCHS/NVSS	Requires funding, eligibility, supply constraints, and state implementation treatment.
5	Will final 2030 U.S. TFR be higher than {total_fertility_rate} if fertility-treatment or IVF coverage is enacted?	Health coverage policy	CDC/NCHS/NVSS	Requires covered treatments, insurer scope, public/private coverage, and effective date.
6	Will final 2030 U.S. TFR be higher than {total_fertility_rate} if family housing support is enacted?	Housing support	CDC/NCHS/NVSS	Requires eligibility, geography, funding, and whether state programs count.

State policy variants should be reviewed separately because a state-level policy may not be an appropriate trigger for a national U.S. fertility-rate outcome without additional design work.

18. Evidence Index

#	Source / Document	Type	URL / Location	Relevance
1	CDC/NCHS Birth Data	Official U.S. source	https://www.cdc.gov/nchs/nvss/births.htm	Primary source candidate for final U.S. birth and fertility publications.
2	CDC WONDER Natality documentation	Official U.S. data documentation	https://wonder.cdc.gov/wonder/help/natality.html	Supporting primary evidence for natality data, rates, and auditability.
3	UN World Population Prospects	International harmonized demographic source	https://population.un.org/wpp/	Secondary source for cross-country comparable TFR context.
4	World Bank SP.DYN.TFRT.IN metadata	Aggregated demographic indicator metadata	https://databank.worldbank.org/metadataglossary/world-development-indicators/series/SP.DYN.TFRT.IN	Fallback indicator source after review.
5	Policy Source	Official legal source	[insert URL]	Determines Policy Trigger satisfaction.

19. Final Notes

This specification is intended to support internal product, compliance, operations, surveillance, and legal review. It is designed to make the proposed conditional event contract more precise, objective, settlement-ready, and operationally reviewable.

The example does not assert that any policy will increase or decrease fertility. It only specifies how a conditional threshold contract could be drafted so that the policy trigger, demographic source, settlement timing, and no-determination treatment are separated clearly.